Apex Biotechnology Corp. (1733.TW) TAI

31.40

+0.15(+0.48%)

Updated at December 05 10:29AM

Currency In TWD

Valuation

Market Cap3.02B
Enterprise Value2.65B
P/E Ratio19.18
PEG Ratio15.44
Price/Sales Ratio1.55
Price/Book Ratio1.74
Enterprise/Revenue1.34
Enterprise/EBITDA10.61

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.1

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue1.85B
Revenue/Share20.57
Gross Profit521.34M
EBITDA221.58M
Net Income128M
Diluted EPS1.27

Balance Sheet

Total Cash674.74M
Total Cash/Share6.83
Total Debt148.18M
Total Debt/Equity0.08
Current Ratio3.3
Book Value Per Share18.13

Price History

52-Week Change10.53
52-Week High38.7
52-Week Low26.4
Moving Average 50 Days33.33
Moving Average 200 Days31.15

Statistics

Average Volume704,807
Shares Outstanding99.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.2
Trailing Annual Dividend Yield3.81
Payout Ratio0
Last Split Factor23:20
Last Split DateJuly 01, 2009